Title |
Type II endoleaks: challenges and solutions
|
---|---|
Published in |
Vascular Health and Risk Management, March 2016
|
DOI | 10.2147/vhrm.s81275 |
Pubmed ID | |
Authors |
Andrew Brown, Greta K Saggu, Matthew J Bown, Robert D Sayers, David A Sidloff |
Abstract |
Type II endoleaks are the most common endovascular complications of endovascular abdominal aortic aneurysm repair (EVAR); however, there has been a divided opinion regarding their significance in EVAR. Some advocate a conservative approach unless there is clear evidence of sac expansion, while others maintain early intervention is best to prevent adverse late outcomes such as rupture. There is a lack of level-one evidence in this challenging group of patients, and due to a low event rate of complications, large numbers of patients would be required in well-designed trials to fully understand the natural history of type II endoleak. This review will discuss the imaging, management, and outcome of patients with isolated type II endoleaks following infra-renal EVAR. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 50% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 3 | 50% |
Members of the public | 2 | 33% |
Scientists | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 81 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 13 | 16% |
Student > Master | 11 | 14% |
Student > Bachelor | 10 | 12% |
Researcher | 8 | 10% |
Student > Postgraduate | 7 | 9% |
Other | 15 | 19% |
Unknown | 17 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 53% |
Engineering | 7 | 9% |
Unspecified | 1 | 1% |
Biochemistry, Genetics and Molecular Biology | 1 | 1% |
Immunology and Microbiology | 1 | 1% |
Other | 3 | 4% |
Unknown | 25 | 31% |